GRK2 suppresses lymphomagenesis by inhibiting the MALT1 proto-oncoprotein
Journal of Clinical Investigation2020cited by 17position: lastdoi
Ibrutinib significantly inhibited Bruton’s tyrosine kinase (BTK) phosphorylation,<i>in-vitro</i> proliferation and enhanced overall survival in a preclinical Burkitt lymphoma (BL) model